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Abstract 
Both the neuropeptide Y (NPY) and the leptin systems have been shown to be important 
central mediators of bone metabolism. However, the interaction between these two systems is 
complex and not fully understood. Here, we show that a unique interaction exists between Y2 
and Y4 receptors in the regulation of bone homeostasis that is not evident when combined 
with lack of Y1 signalling. Despite the hypoleptinaemia shown in male Y2/Y4 double knockout 
(Y2−/−Y4−/−) mice, when on the leptin-deficient ob/ob background, these mice display 
reduced cancellous bone mass. However, combined Y2/Y4 deletion enhances the effect of 
leptin deficiency on the cortical bone compartment. By replicating the enhanced central NPY 
expression evident in ob/ob mice using virally mediated overexpression of NPY in the 
hypothalamus of Y receptor knockout mice, we demonstrate that Y2−/−Y4−/− mice have an 
exaggerated response to the anti-osteogenic effects of elevated hypothalamic NPY in both 
cancellous and cortical bone and that this effect appears to be dependent on Y1 receptor 
signalling. This study highlights the complex interaction between Y receptors in the control of 
bone mass. Moreover, it suggests that the reduction in cortical bone observed in the absence 
of leptin is due to the anti-osteogenic effect of elevated hypothalamic NPY levels. 
 
Introduction 
The understanding of the important role that neuronal signals play in the regulation of 
skeletal tissue has increased markedly in recent years following the identification of several 
powerful, centrally mediated pathways linking the brain to the control of bone mass, through 
the modulation of osteoblast activity. One such example involves neuropeptide Y (NPY)-
mediated signalling through Y2 receptors expressed in neurons of the hypothalamus (Baldock 
et al. 2002). A second pathway involves leptin signalling via its hypothalamic receptor (Ducy 
et al. 2000) to β2 adrenergic receptors in the osteoblast (Takeda et al. 2002). Y2 and leptin 
receptors are co-expressed on NPY neurons in the arcuate nucleus and have been shown to 
interact in mediating leptin’s effects on energy homeostasis (Baskin et al. 1999); however, 
their relationship in the control of bone mass is uncertain. Studies in the leptin-deficient state 
have returned conflicting results. Y2 receptor and leptin-deficient double mutant mice 
(Y2−/−;ob/ob) displayed no additive effect on cancellous bone volume or osteoblast activity, 
suggesting the two pathways may share certain common elements in the control of bone 
homeostasis (Baldock et al. 2005). However, a subsequent study provided clear evidence that 
independent actions also exist, as greater cortical bone formation was observed in 
Y2−/−;ob/ob compared to ob/ob mice, while bone resorption was elevated in the leptin-
deficient models but was unchanged in Y2−/− mice (Baldock et al. 2006). Adding to this 
complexity, as circulating leptin levels increase, the independence of the two pathways 
becomes more apparent. Particularly at normal or elevated leptin levels, the lack of Y2 
receptor signalling induces a clear increase in bone formation compared to Y2 intact controls 
(Baldock et al. 2005). 
 The source of this varied interaction between the NPY and leptin pathways may 
relate, in part, to the complexity of the NPY system. Superficially, NPY’s effect on bone reveals 
a relatively simple inverse relationship. Mice deficient in NPY display enhanced bone mass in 
both the cancellous and cortical compartments due to increased osteoblast activity whilst 
viral-mediated overexpression of NPY specifically in the hypothalamus of mice leads to 
decreased bone mass and osteoblast activity, despite markedly increased body weight and 
adiposity (Baldock et al. 2009). However, NPY is known to act through at least five different Y 
receptors, which have varied and widespread expression. Studies using germline knockout 
mice have revealed a definitive role for both Y1 and Y2 receptors in the regulation of bone 
mass. Whilst Y2 receptors act in the hypothalamus to inhibit osteoblast activity (Baldock et al. 2002), Y1 receptors inhibit bone metabolism via direct actions on bone cells (Baldock et al. 2007; Lee et al. 2010). Furthermore, no additive effect on bone mass was observed with 
deletion of both Y1 and Y2 receptors, suggesting that they may act at different points along the 
same pathway with respect to the control of bone formation (Baldock et al. 2007). 
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 However, the role of Y receptors in the regulation of bone mass is more complex. Y2 
receptors have been shown to be inhibitory autoreceptors (Zhang et al. 1997). Thus, the loss 
of Y2 receptors increases NPY production in the hypothalamus, a change even more apparent 
in double Y2 and Y4 knockout (Y2−/−Y4−/−) mice (Sainsbury et al. 2003). This increased 
NPY expression in the arcuate nucleus of the hypothalamus would be expected to decrease 
bone formation, but bone formation is in fact increased in Y2−/− mice and even more so in 
Y2−/−Y4−/− mice (Sainsbury et al. 2003). The mechanism behind this seeming contradiction 
is unclear. Whilst the deletion of Y4 receptors had no obvious effect on bone homeostasis in 
mice (Sainsbury et al. 2003), the combined deletion of both Y2 and Y4 receptors produced a 
further increase in bone compared to Y2−/− mice (Sainsbury et al. 2003). Interestingly, this 
synergism was evident only in male Y2−/−Y4−/− mice and was coincident with a gender-
specific lean phenotype and a threefold decrease in serum leptin (Sainsbury et al. 2003). 
Leptin deficiency is associated with increased cancellous bone volume (Ducy et al. 2000) but 
reduced cortical bone mass (Baldock et al. 2006). Similarly, the Y2−/−Y4−/−-mediated 
reduction in circulating leptin levels was coincident with an increase in cancellous bone 
volume and a decrease in cortical bone mass compared to normoleptinaemic Y2−/− mice 
(Sainsbury et al. 2003). Moreover, an effect of combined Y2 and Y4 receptor deficiency on 
femoral bone mineral density and bone mineral content was also evident in both male and 
female ob/ob mice (Lee et al. 2008a). Thus, the Y2−/−Y4−/− model as well as its gender-
specific effect on leptin production presents an opportunity to dissect in more detail the 
relationship between Y receptor and leptin signalling to bone and presents a model of an 
additive interaction between the Y receptor and leptin pathways that was not evident in the 
Y2−/−;ob/ob model. It also presents an opportunity to examine the conflicting relationship 
between elevated NPY levels and Y receptor deletion in the hypothalamus. 
 In order to further investigate possible interactions between the different Y receptor-
mediated bone anabolic pathways, we initially compared Y2−/−Y4−/− mice with Y1−/−Y2−/−, 
Y1−/−Y4−/− and Y1−/−Y2−/−Y4−/− mice to examine the possibility of a unique response in 
the Y2−/−Y4−/− model. Subsequently, the interaction with leptin signalling was investigated 
by the deletion of various Y receptor combinations in the absence of leptin using ob/ob mice 
and in the presence of excess leptin by employing viral-mediated overexpression of NPY in the 
hypothalamus. 
 
Materials and Methods 
 
Generation of Germline Y Receptor Knockout Mice 
 
Germline deletion of Y1, Y2 and Y4 receptor genes was achieved as previously described 
(Sainsbury et al. 2002a, b; Howell et al. 2003). Double or triple knockout mice were obtained 
by crossing Y1, Y2 or Y4 knockout mice, respectively. Different Y receptor knockout mice were 
then crossed with heterozygous Ob/ob mice to obtain Y2−/−;ob/ob, Y4−/−;ob/ob and 
Y2−/−Y4−/−;ob/ob mice. All mice generated were maintained on a mixed C57/BL6-129/SvJ 
background. Mice were group-housed under conditions of controlled temperature (22°C) and 
illumination (12-h light cycle, lights on at 07:00 h) and were maintained on standard rodent 
chow (8% calories from fat, 21% calories from protein, 71% calories from carbohydrate, 
2.6 kcal/g; Gordon’s Speciality Stock Feeds, Yanderra, NSW, Australia) ad libitum. All 
research and animal care procedures were approved by the Garvan Institute/St Vincent’s 
Hospital Animal Experimentation Ethics Committee and were in agreement with the 
Australian Code of Practice for the Care and Use of Animals for Scientific Purpose. 
 
Virus Injections 
 
Adult mice were anaesthetised with a single dose of ketamine/xylazine (100 mg/kg and 
20 mg/kg; ip) and injected with adenoassociated virus (AAV) expressing either NPY or an 
empty vector control as previously described (Lin et al. 2006). 
 
Tissue Collection and Analysis 
 
Mice were injected with calcein (20 mg/kg) 10 and 3 days prior to tissue collection and killed 
by cervical dislocation at 16 weeks of age. Femurs and tibias were excised, fixed overnight in 
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4% paraformaldehyde in phosphate-buffered saline at 4°C and then stored in 70% ethanol at 
4°C before undergoing processing. 
 
 
Bone Densitometry Analysis 
 
Whole body bone mineral density and bone mineral content were measured in anaesthetised 
mice using a dedicated mouse dual X-ray absorbitometry (DXA) (Lunar Piximus II, GE 
Medical Systems, Madison, WI, USA) 3 days prior to tissue collection. In addition, excised 
individual femora and tibiae were scanned following collection, fixation and removal of soft 
tissue. 
 
Histomorphometry 
 
Following fixation, the right femora were bisected transversely at the midpoint of the shaft, 
and the distal halves embedded and undecalcified in methyl-methacrylate (APS Chemicals, 
Sydney, Australia). Five-micrometre sagittal sections were analysed as previously described 
(Baldock et al. 2002). Briefly, cancellous bone volume (BV/TV, percent), trabecular number 
(number/millimetre) and trabecular thickness (micrometre) were calculated from von Kossa-
stained sections whilst osteoclast surface (percent) was used to estimate bone resorption from 
sections stained for tartrate-resistant acid phosphatase activity. Mineral apposition rate 
(MAR, micrometre/day) was used to estimate bone formation from unstained sections. All 
analysis was carried out using Leica QWin analysis software (Leica Microsystems Ltd., 
Heerberg, Switzerland). 
 
Statistical Analyses 
 
All data are expressed as means±SEM. Differences between groups were assessed by ANOVA, 
followed by Tukey’s post hoc tests if an overall significance was detected by ANOVA. 
Statistical analyses were performed with SPSS for Mac OS X, version 17.0 (SPSS Inc., Chicago, 
IL, USA). For all statistical analyses, p  <  0.05 was accepted as being statistically significant. 
 
Results 
 
Greater Elevation of Cancellous Bone Volume in Male But not Female Y2−/−Y4−/− Mice 
 
In order to delineate the interactions between various Y receptors on the control of bone 
mass, cancellous bone of the distal femoral metaphyses was examined in wild-type, double 
Y1−/−Y2−/−, Y1−/−Y4−/−, Y2−/−Y4−/− and triple Y1−/−Y2−/−Y4−/− knockout mice. Firstly, 
it is important to note that previous studies investigating the effects of multiple Y receptor 
deficiencies on energy homeostasis have shown that body weight under chow-fed conditions 
is similar in all groups of mice investigated here, except for Y1−/−Y4−/− mice which showed 
significant increases in body weight compared to wild-type (Sainsbury et al. 2006). In 
addition, both Y2−/−Y4−/− and Y1−/−Y2−/−Y4−/− mice showed decreased adiposity 
(Sainsbury et al. 2003, 2006), although this was more pronounced in the Y2−/−Y4−/− mice 
which also showed decreased serum leptin levels. Importantly, however, serum levels of 
corticosterone, free T4, glucose, testosterone and insulin-like growth factor-1 were all similar 
between groups and were not different from wild-type levels (Sainsbury et al. 2006). 
 In male mice, all Y receptor models investigated displayed elevated cancellous bone 
volume, although it failed to reach statistical significance in the Y1−/−Y2−/−Y4−/− line 
(Fig. 1a). This increase in bone volume was associated with significantly increased trabecular 
thickness (Fig. 1c) and mineral apposition rate (Fig. 1d) compared to wild-type mice. In 
addition, the greatest elevation in cancellous bone volume was evident in male Y2−/−Y4−/− 
double knockout mice (Fig. 1a). This marked increase in cancellous bone volume in male 
Y2−/−Y4−/− mice was associated with greater trabecular number (Fig. 1b) and mineral 
apposition rate (Fig. 1d) compared with wild-type and other double and triple knockout mice 
investigated. However, no interaction was evident in any of the other models investigated 
where cancellous bone volume and mineral apposition rate were increased only to levels 
similar to that previously shown in single Y1−/− and Y2−/− mice (Baldock et al. 2002, 2007). 
Interestingly, the marked effects of double Y2 and Y4 receptor deletion on cancellous bone 
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volume (Fig. 1a), trabecular number (Fig. 1b) and osteoblast activity (Fig. 1d) were no longer 
evident when combined with Y1 receptor deletion. 
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Figure 1 Effect of Y receptor
deficiencies on cancellous bone
volume, osteoblast activity and
osteoclast activity. a Cancellous
bone volume (BV/TV),
b trabecular number,
c trabecular thickness,
d mineral apposition rate (MAR)
and e osteoclast surface in male
and female mice at 16 weeks of
age. Mean±SEM of 3–16 mice
per group are shown. ⋆p<0.05,
⋆⋆p<0.01, ⋆⋆⋆p<0.001
compared to wild-type or as
indicated. WT, wild-type; Y1Y2,
Y1−/−Y2−/−; Y1Y4, Y1−/−Y4−/−;
Y2Y4, Y2−/−Y4−/−; Y1Y2Y4,
Y1−/−Y2−/−Y4−/−
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 In female mice, cancellous bone volume was similarly elevated in all Y receptor-
deficient models compared to control, with no differences between models (Fig. 1a). This 
increase was associated with enhanced bone formation as demonstrated by significantly 
increased mineral apposition rate in all models compared to wild-type (Fig. 1d). Despite the 
lack of a greater effect in female Y2−/−Y4−/− mice compared to other knockout models 
studied, the elevated cancellous bone volume in female Y2−/−Y4−/− mice was associated with 
increased trabecular number (Fig. 1b) whereas in the other Y receptor-deficient models it was 
associated with increased trabecular thickness (Fig. 1c). 
 Interestingly, bone resorption was also elevated in both male and female double 
Y2−/−Y4−/− knockout mice as demonstrated by significantly increased osteoclast surface 
compared to wild-type and other Y receptor-deficient models investigated (Fig. 1e). Again, 
this effect was no longer evident when combined with Y1 receptor deletion. Thus, these data 
reveal a unique interaction between Y1, Y2 and Y4 receptor signalling in both the osteoblastic 
and osteoclastic regulation of cancellous bone mass, albeit one that is more pronounced in 
male animals. 
 
Combined Lack of Y2, Y4 and Leptin Signalling Does not Increase Cancellous Bone Mass 
 
The data presented above suggest a unique skeletal response to combined Y2 and Y4 receptor 
deletion (in the absence of Y1 deficiency) resulting in enhanced cancellous bone mass. 
Previous studies also identified a reduction in cortical bone mass in these mice (Sainsbury et 
al. 2003). This opposing response between the two bone envelopes is consistent with the 
skeletal effects of hypoleptinaemia known to be present in male Y2−/−Y4−/− mice (Sainsbury 
et al. 2003). To examine the dependence of the Y2−/−Y4−/− skeletal phenotype upon 
coincident leptin deficiency, Y2−/−, Y4−/− and Y2−/−Y4−/− mice were crossed onto the 
leptin-deficient, ob/ob background. In contrast to findings in leptin-intact models above 
(Fig. 1), in the complete absence of leptin, cancellous bone volume was not greater in 
Y2−/−Y4−/− mice than in other models (Fig. 2a), nor was trabecular thickness or trabecular 
number (data not shown). Moreover, the levels of cancellous bone volume in leptin-deficient 
models was not greater than that shown in leptin-intact models in Fig. 1a. 
 
 
 
 
  
the lack of a greater effect in female Y2−/−Y4−/− mice
compared to other knockout models studied, the elevated
cancellous bone volume in female Y2−/−Y4−/− mice was
associated with increased trabecular number (Fig. 1b)
whereas in the other Y receptor-deficient models it was
associated with increased trabecular thickness (Fig. 1c).
Interestingly, bone resorption was also elevated in both
male and female double Y2−/−Y4−/− knockout mice as
demonstrated by significantly increased osteoclast surface
compared to wild-type and other Y receptor-deficient
models investigated (Fig. 1e). Again, this effect was no
longer evident when combined with Y1 receptor deletion.
Thus, these data reveal a unique interaction between Y1,
Y2 and Y4 receptor signalling in both the osteoblastic and
osteoclastic regulation of cancellous bone mass, albeit one
that is more pronounced in male animals.
Combined Lack of Y2, Y4 and Leptin Signalling Does
not Increase Cancellous Bone Mass
The data presented above suggest a unique skeletal
response to combined Y2 and Y4 receptor deletion (in the
absence of Y1 deficiency) resulting in enhanced cancellous
bone mass. Previous studies also identified a reduction in
cortical bone mass in these mice (Sainsbury et al. 2003).
This opposing response between the two bone envelopes is
consistent with the skeletal effects of hypoleptinaemia
known to be present in male Y2−/−Y4−/− mice (Sainsbury
et al. 2003). To examine the dependence of the Y2−/−Y4−/−
skeletal phenotype upon coincident leptin deficiency, Y2−/−,
Y4−/− and Y2−/−Y4−/− mice were crossed onto the leptin-
deficient, ob/ob background. In contrast to findings in
leptin-intact models above (Fig. 1), in the complete absence
of leptin, cancellous bone volume was not greater in
Y2−/−Y4−/− mice than in other models (Fig. 2a), nor was
trabecular thickness or trabecular number (data not shown).
Moreover, the levels of cancellous bone volume in leptin-
deficient models was not greater than that shown in leptin-
intact models in Fig. 1a.
Interestingly, the cancellous bone volume of Y2−/−Y4−/−;
ob/ob mice was not significantly different to wild-type
levels (Fig. 2a), suggesting that the unique increase in
cancellous bone volume and osteoblast activity in male
Y2−/−Y4−/− mice (Fig. 1) may not involve a direct response
to hypoleptinaemia. However, it does still indicate the
potential for unique signalling to bone in the absence of
both Y2 and Y4 receptors.
Conversely, cortical bone mass of Y2−/−Y4−/−;ob/ob mice
was decreased, as indicated by long bone length, known to be
reduced in ob/ob mice (Hamrick et al. 2004), which was
further reduced following the additional loss of both Y2 and
Y4 receptor signalling in both male and female mice
(Fig. 2b). This is in addition to previously described
significant reductions in femoral bone mineral density and
bone mineral content in both sexes of Y2−/−Y4−/−;ob/ob mice
compared to wild-type, even in the absence of correction for
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Figure 2 Effect of Y2, Y4 and
double Y2, Y4 receptor
deficiency on cancellous bone
volume and femur length. a
Cancellous bone volume
(BV/TV), b femur length in
male and female mice at
16 weeks of age. Mean±SEM
of 4–10 mice per group are
shown. ⋆p<0.05, ⋆⋆p<0.01,
⋆⋆⋆p<0.001 compared to
wild-type or as indicated. WT,
wild-type; ob, ob/ob; Y2ob,
Y2−/−;ob/ob; Y4ob, Y4−/−;ob/ob;
Y2Y4ob, Y2−/−Y4−/−;ob/ob
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 Interestingly, the cancellous bone volume of Y2−/−Y4−/−;ob/ob mice was not 
significantly different to wild-type levels (Fig. 2a), suggesting that the unique increase in 
cancellous bone volume and osteoblast activity in male Y2−/−Y4−/− mice (Fig. 1) may not 
involve a direct response to hypoleptinaemia. However, it does still indicate the potential for 
unique signalling to bone in the absence of both Y2 and Y4 receptors. 
 Conversely, cortical bone mass of Y2−/−Y4−/−;ob/ob mice was decreased, as 
indicated by long bone length, known to be reduced in ob/ob mice (Hamrick et al. 2004), 
which was further reduced following the additional loss of both Y2 and Y4 receptor signalling 
in both male and female mice (Fig. 2b). This is in addition to previously described significant 
reductions in femoral bone mineral density and bone mineral content in both sexes of 
Y2−/−Y4−/−;ob/ob mice compared to wild-type, even in the absence of correction for body 
weight (Lee et al. 2008a). Critically, this reduction was also evident compared to ob/ob mice 
and was not apparent in either Y2−/−;ob/ob or Y4−/−;ob/ob mice (Fig. 2b), suggesting that 
even when leptin levels were constant Y2−/−Y4−/− mice responded more strongly than other 
genotypes. 
 
Y2−/−Y4−/− Mice Exhibit Enhanced Responses to Hypothalamic NPY 
 
The cortical effects of leptin deficiency seen in ob/ob mice, which act in opposition to 
cancellous changes, have been postulated to result from the elevated hypothalamic NPY levels 
resulting from loss of leptin signalling (Lee et al. 2008b). Thus, the greater cortical changes 
evident in Y2−/−Y4−/−;ob/ob mice may represent an enhanced response to hypothalamic 
NPY signalling rather than a generalised effect of leptin deficiency. Moreover, the reduced 
cancellous bone seen in Y2−/−Y4−/−;ob/ob mice further indicates that loss of Y2 and Y4 
receptor signalling induces elevated responses to hypothalamic NPY. This hypothesis was 
investigated by specifically overexpressing NPY in the hypothalamus of male wild-type, 
Y2−/−, Y2−/−Y4−/− and Y1−/−Y2−/−Y4−/− knockout mice using a virally mediated 
technique. Increased central NPY expression reduced tibial bone mass (as determined by 
DXA on isolated bones) in wild-type and Y2−/− mice as previously reported (Fig. 3 and 
Baldock et al. 2005). However, tibial bone mineral density (Fig. 3a) and bone mineral content 
(Fig. 3b) were reduced to significantly lower levels in Y2−/−Y4−/− mice compared to the other 
genotypes investigated, despite equivalent NPY expression (data not shown). Indeed, the 
percentage change in both tibial bone mineral density and tibial bone mineral content in 
NPY-treated mice compared to empty control was two- to threefold greater in Y2−/−Y4−/− 
mice than other genotypes (Fig. 3c), indicating the existence of a unique response pattern in 
these mice which is no longer apparent when combined with Y1 receptor deletion. 
 It is interesting to note that these decreases in bone mass following NPY 
overproduction occurred despite marked (50–70%) increases in body weight (Lin et al. 2006). 
That bone mass increases consistently with body weight is one of the most fundamental 
relationships in skeletal biology (Reid 2008). Thus, the loss of bone following NPY 
overproduction is evidence of the power of the anti-osteogenic pathway induced by central 
NPY signalling. As with skeletal changes, body weight changes were attenuated between 
Y2−/−Y4−/− and Y1−/−Y2−/−Y4−/− mice, further indicating the importance of Y1 receptor 
signalling in the absence of Y2 and Y4 receptors (Lin et al. 2006). 
             We next investigated whether the unique skeletal effect of elevated hypothalamic NPY 
in Y2−/−Y4−/− mice is also evident in cancellous bone. As shown in Fig. 4, increased central 
NPY expression did not alter cancellous bone volume, trabecular thickness or trabecular 
number in wild-type mice. However, it did abolish the elevated cancellous bone volume 
(Fig. 4a) and trabecular thickness (Fig. 4b) evident in all Y receptor knockout models 
investigated. Trabecular number, only elevated in the Y2−/−Y4−/− model, was also 
significantly reduced in the NPY overproducing Y2−/−Y4−/− group (Fig. 4c). Interestingly, 
the magnitude of change in cancellous bone volume caused by elevated NPY levels in the 
Y2−/−Y4−/− double knockout mice (−82%) was double that exhibited by Y2−/− and 
Y1−/−Y2−/−Y4−/− mice (−44% and −45%, respectively). 
             Together, these data show that combined Y2 and Y4 receptor deletion in mice leads to 
an enhanced response to central NPY levels in both cortical and cancellous bone. 
Interestingly, the additional deletion of the Y1 receptor eliminates this unique response. 
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body weight (Lee et al. 2008a). Critically, this reduction was
also evident compared to ob/ob mice and was not apparent in
either Y2−/−;ob/ob or Y4−/−;ob/ob mice (Fig. 2b), suggesting
that even when leptin levels were constant Y2−/−Y4−/− mice
responded more strongly than other genotypes.
Y2−/−Y4−/− Mice Exhibit Enhanced Responses
to Hypothalamic NPY
The cortical effects of leptin deficiency seen in ob/ob mice,
which act in opposition to cancellous changes, have been
postulated to result from the elevated hypothalamic NPY
levels resulting from loss of leptin signalling (Lee et al.
2008b). Thus, the greater cortical changes evident in Y2−/
−Y4−/−;ob/ob mice may represent an enhanced response to
hypothalamic NPY signalling rather than a generalised
effect of leptin deficiency. Moreover, the reduced cancel-
lous bone seen in Y2−/−Y4−/−;ob/ob mice further indicates
that loss of Y2 and Y4 receptor signalling induces elevated
responses to hypothalamic NPY. This hypothesis was
investigated by specifically overexpressing NPY in the
hypothalamus of male wild-type, Y2−/−, Y2−/−Y4−/− and
Y1−/−Y2−/−Y4−/− knockout mice using a virally mediated
technique. Increased central NPY expression reduced tibial
bone mass (as determined by DXA on isolated bones) in
wild-type and Y2−/− mice as previously reported (Fig. 3 and
Baldock et al. 2005). However, tibial bone mineral density
(Fig. 3a) and bone mineral content (Fig. 3b) were reduced
to significantly lower levels in Y2−/−Y4−/− mice compared
to the other genotypes investigated, despite equivalent NPY
expression (data not shown). Indeed, the percentage change
in both tibial bone mineral density and tibial bone mineral
content in NPY-treated mice compared to empty control
was two- to threefold greater in Y2−/−Y4−/− mice than other
genotypes (Fig. 3c), indicating the existence of a unique
response pattern in these mice which is no longer apparent
when combined with Y1 receptor deletion.
It is interesting to note that these decreases in bone mass
following NPY overproduction occurred despite marked
(50–70%) increases in body weight (Lin et al. 2006). That
bone mass increases consistently with body weight is one
of the most fundamental relationships in skeletal biology
(Reid 2008). Thus, the loss of bone following NPY
overproduction is evidence of the power of the anti-
osteogenic pathway induced by central NPY signalling.
As with skeletal changes, body weight changes were
attenuated between Y2−/−Y4−/− and Y1−/−Y2−/−Y4−/− mice,
further indicating the importance of Y1 receptor signalling
in the absence of Y2 and Y4 receptors (Lin et al. 2006).
We next investigated whether the unique skeletal effect
of elevated hypothalamic NPY in Y2−/−Y4−/− mice is also
evident in cancellous bone. As shown in Fig. 4, increased
central NPY expression did not alter cancellous bone
volume, trabecular thickness or trabecular number in wild-
type mice. However, it did abolish the elevated cancellous
bone volume (Fig. 4a) and trabecular thickness (Fig. 4b)
evident in all Y receptor knockout models investigated.
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Figure 3 Effect of Y receptor deficiencies on the cortical bone
response to elevated hypothalamic NPY. a Tibial bone mineral density
(BMD) and b tibial bone mineral content (BMC) in male mice 3 weeks
after AAV vector injection. c Percent change in tibial BMD and BMC
in NPY overexpressing mice compared to empty controls. Mean±SEM
of 3–12 mice per group are shown. ⋆p<0.05, ⋆⋆⋆p<0.001 as
indicated. WT, wild-type; Y2, Y2−/−; Y2Y4, Y2−/−Y4−/−; Y1Y2Y4,
Y1−/−Y2−/−Y4−/−
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Trabecular number, only elevated in the Y2−/−Y4−/− model,
was also significantly reduced in the NPY overproducing
Y2−/−Y4−/− group (Fig. 4c). Interestingly, the magnitude of
change in cancellous bone volume caused by elevated NPY
levels in the Y2−/−Y4−/− double knockout mice (−82%) was
double that exhibited by Y2−/− and Y1−/−Y2−/−Y4−/− mice
(−44% and −45%, respectively).
Together, these data show that combined Y2 and Y4
receptor deletion in mice leads to an enhanced response to
central NPY levels in both cortical and cancellous bone.
Interestingly, the additional deletion of the Y1 receptor
eliminates this unique response.
Discussion
Results from this study help to delineate the complex
interaction between the NPY and the leptin systems on bone
homeostasis. In particular, we show that the unique
interaction between Y2 and Y4 receptors is not seen with
other Y receptor combinations such as Y1/Y2 double
knockout as well as Y1/Y4 double knockout. Importantly,
these data also demonstrate that the major effects of Y2 and
Y4 deletion on bone are lost when combined with Y1
receptor deletion. Furthermore, the combined lack of Y2
and Y4 receptor signalling reduces the potent effect of
leptin deficiency to promote cancellous bone mass whilst
exacerbating the effect of leptin deficiency to decrease
cortical bone. This phenotype is consistent with an
exaggerated response to the anti-osteogenic actions of
increased hypothalamic NPY that is secondary to the loss
of leptin as demonstrated by the extreme loss of both
cancellous and cortical bone shown in Y2−/−Y4−/− mice
with viral overexpression of hypothalamic NPY.
The NPY-mediated regulation of bone mass has been
shown to involve signalling via central Y2 receptors
(Baldock et al. 2002) and osteoblastic Y1 receptors (Lee
et al. 2010). In contrast, the Y4 receptor and its primary
ligand pancreatic polypeptide (PP) do not appear to play a
role in bone (Sainsbury et al. 2003; Wortley et al. 2007).
However, the unique skeletal changes in Y2−/−Y4−/− mice
present an opportunity to examine the system more closely:
in particular, the interaction between NPY and leptin-
deficient regulation of bone mass. Hypoleptinaemic male
Y2−/−Y4−/− mice display a unique increase in cancellous
bone volume coincident with reduced cortical bone mass
(Sainsbury et al. 2003). This phenotype was not present
with any other combination of Y receptor deletion
investigated and suggests an interaction between the NPY-
deficient (Baldock et al. 2009) and β2 adrenergic-deficient
(Takeda et al. 2002) regulation of osteoblast activity, as
evident in NPY knockout and leptin-deficient ob/ob mice,
respectively.
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Figure 4 Effect of Y receptor deficiencies on the cancellous bone
response to elevated hypothalamic NPY. a Cancellous bone volume
(BV/TV), b trabecular thickness and c trabecular number in male mice
3 weeks after AAV vector injection. Mean±SEM of 3–13 mice per
group are shown. ⋆p<0.05, ⋆⋆p<0.01, ⋆⋆⋆p<0.001 as indicated. WT,
wild-type; Y2, Y2−/−; Y2Y4, Y2−/−Y4−/−; Y1Y2Y4, Y1−/−Y2−/−Y4−/−
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Discussion 
Results from this study help to delineate the complex interaction between the NPY and the 
leptin systems on bone homeostasis. In particular, we show that the unique interaction 
between Y2 and Y4 receptors is not seen with other Y receptor combinations such as Y1/Y2 
double knockout as well as Y1/Y4 double knockout. Importantly, these data also demonstrate 
that the major effects of Y2 and Y4 deletion on bone are lost when combined with Y1 receptor 
deletion. Furthermore, the combined lack of Y2 and Y4 receptor signalling reduces the potent 
effect of leptin deficiency to promote cancellous bone mass whilst exacerbating the effect of 
leptin deficiency to decrease cortical bone. This phenotype is consistent with an exaggerated 
response to the anti-osteogenic actions of increased hypothalamic NPY that is secondary to 
the loss of leptin as demonstrated by the extreme loss of both cancellous and cortical bone 
shown in Y2−/−Y4−/− mice with viral overexpression of hypothalamic NPY. 
 The NPY-mediated regulation of bone mass has been shown to involve signalling via 
central Y2 receptors (Baldock et al. 2002) and osteoblastic Y1 receptors (Lee et al. 2010). In 
contrast, the Y4 receptor and its primary ligand pancreatic polypeptide (PP) do not appear to 
play a role in bone (Sainsbury et al. 2003; Wortley et al. 2007). However, the unique skeletal 
changes in Y2−/−Y4−/− mice present an opportunity to examine the system more closely: in 
particular, the interaction between NPY and leptin-deficient regulation of bone mass. 
Hypoleptinaemic male Y2−/−Y4−/− mice display a unique increase in cancellous bone volume 
coincident with reduced cortical bone mass (Sainsbury et al. 2003). This phenotype was not 
present with any other combination of Y receptor deletion investigated and suggests an 
interaction between the NPY-deficient (Baldock et al. 2009) and β2 adrenergic-deficient 
(Takeda et al. 2002) regulation of osteoblast activity, as evident in NPY knockout and leptin-
deficient ob/ob mice, respectively. 
 Previous studies examining crosses of either Y1 or Y2 receptor null mice with leptin-
deficient models have failed to identify additive effects in cancellous bone, whilst activities 
were opposing in cortical bone (Baldock et al. 2005, 2006; Allison et al. 2009). In contrast to 
these previously published models, the Y2−/−Y4−/−;ob/ob mice showed a generalised 
reduction of bone mass in both cortical and cancellous bone. Such a phenotype is consistent 
with an exaggerated response to the anti-osteogenic actions of increased hypothalamic NPY 
that is secondary to the loss of leptin (Wilding et al. 1993). Indeed, in addition to the 
exaggerated loss of cortical bone (Lee et al. 2008a), the reduction in cancellous bone volume 
shown here in Y2−/−Y4−/−;ob/ob mice indicates that the elevation of central NPY is capable 
of overcoming the pro-osteogenic actions of the adrenergic pathway. Interestingly, the 
enhanced reduction in cortical bone mass in these mice suggests that the loss of cortical bone 
in ob/ob mice is the result of central NPY signalling. 
 Y2−/−Y4−/− mice, whether leptin intact or leptin deficient, display a complex skeletal 
phenotype suggesting unique responses in these mice. Importantly, however, endocrine 
changes do not explain the unique responses in Y2−/−Y4−/− mice (Sainsbury et al. 2003). 
However, previous studies have identified marked changes in Y receptor binding in the 
hypothalamus in response to the loss of individual Y receptors (Lin et al. 2005), suggesting 
that neural processes may be altered in these mice. Moreover, the Y2−/−Y4−/− phenotype was 
absent in Y1−/−Y2−/−Y4−/− mice, reinforcing the likelihood of a neural mechanism. In order 
to examine the possible changes in signalling present in the hypothalamus of Y2−/−Y4−/− 
mice, a locus-specific elevation in NPY expression was induced in mature mice, using a virally 
mediated approach. This method has the advantage of minimising developmental changes 
associated with leptin deficiency. Increased NPY expression in the arcuate nucleus has been 
shown to induce marked anti-osteogenic activities in bone (Baldock et al. 2005) and results 
were consistent with previous studies. However, Y2−/−Y4−/− mice again displayed a unique 
response, with markedly greater reductions in both cancellous and cortical bone mass, despite 
equivalent increases in NPY. In this manner, the mechanism responsible for the unique 
skeletal response can be isolated to the hypothalamus and further to signalling involving 
arcuate NPY. Importantly, the exaggerated response to arcuate NPY was again normalised in 
Y1−/−Y2−/−Y4−/− mice. This result indicates a critical role of central Y1 receptors in this 
context, likely through modulation of Y1 expression in the paraventricular nucleus, the 
downstream region for signalling of NPY produced in the arcuate (Jhanwar-Uniyal et al. 1993). 
 The interaction between Y receptors in the hypothalamus is clearly complex and 
appears context dependent. In particular, arcuate-specific overexpression of exogenous NPY 
using a virally mediated process highlights the unique skeletal response of Y2−/−Y4−/− mice 
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and the role of Y1 expression in this model. Y2−/−Y4−/− mice showed markedly increased 
anti-osteogenic responses to NPY injection that were corrected by loss of Y1. These 
interrelationships between the receptors of the NPY system and their effects upon peripheral 
tissue homeostasis represent an important consideration in the development of potential 
therapeutic agents. In addition to consideration of the receptor specificity of any such agent, 
the compensatory response by those remaining receptors must also be evaluated. 
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